The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.

During the past decade, Chang Gung Medical Foundation, LinKou Branch conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 32 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 18 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang Gung Medical Foundation, LinKou Branch" #1 sponsor was "Pfizer" with 13 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation, LinKou Branch" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Durect" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation, LinKou Branch" are "Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Attention Deficit Hyperactivity Disorder" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "Chang Gung Medical Foundation, LinKou Branch" in a lesser frequency.

Most popular intervention types in "Chang Gung Medical Foundation, LinKou Branch" are "Drug" (58 trials), "Other" (8 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Paclitaxel" (5 trials), "Atezolizumab" (4 trials), "Carboplatin" (4 trials) and "Gemcitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Medical Foundation, LinKou Branch" are 56 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chang Gung Medical Foundation, LinKou Branch". undefined are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Chang Gung Medical Foundation, LinKou Branch, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Medical Foundation, LinKou Branch, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".